Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Periodontal disease and serum ultrasensitive C-reactive protein and fibrinogen
2019-002239-27Phase 4Active
- Sponsor
- AndreuDental
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of doxycycline in periodontitis, sponsored by AndreuDental. Primary endpoint: Primary: Relationship between periodontal disease and ultrasensitive C-reactive protein and fibrinogen. Started Jul 2019; status: active.
02
Drugs
doxycycline
03
Conditions
periodontitis
Beyond the preview
Go deeper on 2019-002239-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002239-27.